<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v7i3.4806</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Nano-Sustained CO-Releasing Molecules Alleviates Cyclosporin-A-Induced Nephrotoxicity and Renal Fibrosis by Inhibiting NLRP3 Inflammasome-Mediated TGF-β/Smad Signaling Pathway</title><url>https://artdesignp.com/journal/JCNR/7/3/10.26689/jcnr.v7i3.4806</url><author>JiJuan,BiZhaoyu,TianLing,ZhangQian,HouShu-fen,LiSong</author><pub-date pub-type="publication-year"><year>2023</year></pub-date><volume>7</volume><issue>3</issue><history><date date-type="pub"><published-time>2023-05-31</published-time></date></history><abstract>Objective: To investigate the effect nano-sustained CO-releasing molecules on cyclosporin-A (CsA)-induced nephrotoxicity by inhibiting the NLRP3 inflammasome-mediated TGF-β/Smad signaling pathway. Methods: 3×105 cell/mL human renal tubular epithelial cells (HK-2) and mouse primary cultured renal tubular epithelial cells (RTECs) were cultured under an inverted microscope and incubated with 10% DMEM and 0.25% β2M in NaCl solution for 3 h. HK-2 and RTECs were divided into 5 complex numbers. MTT assay was used to detect the relative proliferation level of one of the HK-2 cells and calculate the multiplication ratio. Results: The nano-sustained CO-releasing molecules CS-CO had a strong protective effect on the kidney. HK-2 and RTECs cells were treated with siRNA, inhibitors, and NLRP3 knockout mice, and the changes in cell activity and expression of intracellular inflammatory factors were studied. The expression of TGF-β1/Smad signaling pathway related proteins in HK-2 and RTECs was detected by ELISA, western blot, immunofluorescence, and other techniques. Conclusion: SMA/CORM2 alleviates CsA-induced renal fibrosis by inhibiting NLRP3 inflammasome-mediated TGF-β/Smad signaling pathway.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Tian RF, Li PS, 2022, IFN-? Combined with TNF-? Stimulates Mesenchymal Stem Cells to Relieve Cisplatin- Induced Renal Fibrosis. China Science and Technology Papers Online Quality Papers, 15(03): 318–327.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Jiang Y, 2022, Coenzyme Q10 Inhibits Rip1-RIP3-MLK l- Mediated Necrotic Apoptosis Through Wnt3?/?-catenin/GSK-3? Signaling Pathway to Reduce Renal Fibrosis in Rats with Unilateral Ureteral Obstruction, dissertation, Yanbian University.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Yuan Y, 2022, Study on the Mechanism of Action of Wenyang Zhenshuai Granules on Renal Fibrosis Based on NLRP3 Inflammasome Mediated Pyrodeath, dissertation, Hunan University of Chinese Medicine.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Song G, He J, 2022, Research Progress of SIRT6 and the Mechanism of Diabetic Nephropathy. Chin J Clinical Research, 35(05): 717–720.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Zhou W, 2022, CircPlekha7 Targets miR-493-3p/KLF4 To Inhibit Renal Fibrosis, dissertation, Nanchang University.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Wallace JL, Vaughan D, Dicay M, et al., 2018, Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic, Antioxid Redox Signal 28(16): 1533–1540.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Abraham NG, Kappas A, 2008, Pharmacological and Clinical Aspects of Heme Oxygenase. Pharmacol Rev, 60(1): 79–127.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Boczkowski J, Poderoso JJ, Motterlini R, 2006, CO-Metal Interaction: Vital Signaling from a Lethal Gas, Trends Biochem Sci 31(11): 614–621.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Ghosh S, Gal J, Marczin N, 2010, Carbon Monoxide: Endogenous Mediator, Potential Diagnostic and Therapeutic Target, Ann Med 42(1): 1–12.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Shao L, Liu C, Wang S, Liu J, et al., 2018, The Impact of Exogenous CO Releasing Molecule CORM-2 on Inflammation and Signaling of Orthotopic Lung Cancer, Oncol Lett 16(3): 3223–3230.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Zhang W, Tao A, Lan T, et al., 2017, Carbon Monoxide Releasing Molecule-3 Improves Myocardial Function in Mice with Sepsis by Inhibiting NLRP3 Inflammasome Activation in Cardiac Fibroblasts, Basic Res Cardiol, 112(2): 16.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Foresti R, Bani-Hani BG, Motterlini R, 2008, Use of Carbon Monoxide as a Therapeutic Agent: Promises and Challenges, Intensive Care Med, 34(4): 649–658.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Nagao S, Taguchi KH, Sakai R, et al., 2014, Carbon Monoxide-Bound Hemoglobin-Vesicles for the Treatment of Bleomycin-Induced Pulmonary Fibrosis, Biomaterials 35(24): 6553–6562.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Chaves-Ferreira M, Albuquerque IS, Matak-Vinkovic D, et al., 2015, Spontaneous CO Release from Ru(II)(CO)2-Protein Complexes in Aqueous Solution, Cells, and Mice, Angew Chem Int Ed Engl 54(4):1172–1175.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Santos-Silva T, Mukhopadhyay A, Seixas JD, et al., 2011, CORM-3 Reactivity Toward Proteins: The Crystal Structure of a Ru (II) Dicarbonyl-Lysozyme Complex, J Am Chem Soc 133(5): 1192–1195.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
